Articles tagged with Blood Vessels
Researchers at Brigham and Women's Hospital have successfully fabricated blood vessels using 3D bioprinting technology, addressing a critical challenge in tissue engineering. The approach involves printing agarose fibers that become the blood vessel channels, allowing for physical removal of template layers and improved cell viability.
Researchers discovered that CCL28 and its receptor are key players in angiogenesis, a hallmark of rheumatoid arthritis. This finding provides strong evidence for the binding of CCL28 to joint-lining cells as necessary for blood vessel formation.
Researchers developed a novel compound, Sticky-trap, to treat retinopathy by selectively closing off abnormal blood vessels without affecting healthy ones. The treatment has shown promise in mice and may lead to a new class of pharmacological entities for various conditions.
Researchers found that females susceptible to MS produce higher levels of the blood vessel receptor protein S1PR2 than males, leading to the inflammation that causes MS. The study's findings have implications for developing new treatments, including a drug that disables S1PR2.
Scientists have identified a potential new strategy to treat ovarian cancer by targeting multiple growth factors. By blocking several avenues that tumour cells use to escape eradication, researchers hope to develop new anticancer drugs that target ovarian tumour growth.
Researchers at the Beckman Institute developed a vascular network system that heals fiber-reinforced composites autonomously through polymerization of healing chemistries. This technology overcomes long-standing challenges in composite materials, enabling repeated self-healing and increasing structural reliability.
Professor Thomas Korff's work reduces experimental animals and promotes human umbilical cord cells to mimic vessel walls. His methods decrease animal distress and costs, while improving research results.
Researchers at Brigham and Women's Hospital have identified certain proteins in osteoclasts that may help destroy cardiovascular calcification by dissolving mineral deposits. The discovery suggests a potential therapeutic avenue for patients with cardiovascular calcification.
Scientists have identified perivascular stem cells as a reservoir of HCMV, suggesting a potential treatment target. The discovery could lead to the development of novel targeted therapies to prevent HCMV re-activation and its associated complications.
A recent study by UCLA scientists and colleagues reveals that UV light significantly enhances the ability of melanoma cells to creep along the outside of blood vessels, leading to increased metastasis. The research demonstrates that exposure to UV radiation triggers inflammation, attracting immune cells that promote this process.
Researchers discovered that sunburns contribute to melanoma development through inflammatory processes in surrounding tissue. Melanoma cells migrate along blood vessels in inflamed skin, with activated neutrophils playing a key role in metastasis.
Researchers at Harvard University's Wyss Institute have developed a bioprinting method to create intricately patterned 3D tissue constructs with multiple cell types and tiny blood vessels. The breakthrough enables the creation of thicker, functional tissues that can be used for drug testing and potentially replaced damaged human tissue.
Researchers at Rensselaer Polytechnic Institute have identified a gene associated with congenital diaphragmatic hernia, a life-threatening birth defect. The discovery reveals the genetic root of the physical defect and offers potential routes for intervention.
Researchers developed a gene delivery method targeting tumor blood vessels in mice, avoiding healthy tissues. The approach uses a deactivated virus carrying a gene of interest to hijack abnormal blood vessels and alter the tumor microenvironment.
A study in mice reveals that breakdown of brain blood vessels may amplify problems associated with Alzheimer's disease. Pericytes, a type of blood vessel cell, may provide novel targets for treatments and diagnoses.
New research reveals targeting blood vessel metabolism may block pathological growth by depriving it of energy and building blocks. Partially blocking PFKFB3 reduces blood vessel sprouting and amplifies VEGF blockade effects, offering a new treatment strategy for conditions like cancer, blindness, and inflammatory diseases.
Researchers have identified how golden staph bacteria target and destroy key immune cells, disrupting the body's defense against infection. By visualizing this process using advanced microscopy techniques, the team gained insights into how golden staph evades the immune system and causes tissue damage.
An international team of researchers at Karolinska Institutet in Sweden have discovered a new mechanism that regulates the way blood vessels grow and connect to each other. The discovery provides essential insights into vascular development and could lead to new opportunities for cancer therapy.
Early data from a Polish patient study suggest the investigational bioengineered vessel may be effective as a dialysis graft, with 100% of patients regaining blood flow after initial loss. The technology uses human tissue and has shown no signs of infection or immune reaction.
Researchers discovered that snakes can optimize their vision by controlling blood flow in their eyes when perceiving threats. The coachwhip snake's visual blood flow patterns change depending on its environment, allowing for improved visual clarity in times of need.
Researchers at Scripps Research Institute have developed a promising technique for treating human eye disease by targeting microRNAs, which can stop abnormal blood vessel growth. The approach shows promise in preventing blindness in diseases like neovascular macular degeneration and diabetic retinopathy.
Researchers at the University of Illinois Chicago identified a protein expressed by human bone marrow stem cells that guides blood vessel formation. The study found that mesenchymal stem cells support functional blood vessel growth, and their genetic signature may be used to individualize stem cell treatments for heart patients.
A study published in PLOS ONE found that a topical compound called PPADS can inhibit symptoms associated with both dry and wet AMD, offering promise for a breakthrough treatment. The researchers tested the compound on mice and observed significant reduction in tissue damage and blood vessel growth characteristic of AMD.
A study in Malawian children found chronic inflammation in blood vessels after recurrent malaria episodes, predisposing future infections and cardiovascular disease. The findings explain high childhood mortality rates in malaria-endemic areas.
Researchers have discovered that thyroid hormone affects blood vessel constriction, leading to sensitivity to temperature extremes. This knowledge may help future treatment of patients with thyroid disorders who experience temperature-related symptoms.
Researchers at UNC School of Medicine have found a class of drugs known as MDM2 inhibitors effective in regressing abnormal blood vessels responsible for vision loss associated with macular degeneration. The treatment has potential to reduce the burden on patients and physicians.
A newly discovered compound has been identified as a potential diagnostic marker for zinc status, which can help detect the harmful effects of zinc deficiency in blood vessel cells. This discovery may lead to faster and easier methods for detecting low zinc levels in the body.
A Stanford study found that blocking an inflammation-producing molecular pathway reverses pulmonary hypertension in rats, suggesting a potential cure for the deadly disease. The research could also lead to better understanding of other inflammatory diseases.
A study published in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke.
Researchers have created a new drug-delivery strategy using a biodegradable coating that prolongs the effectiveness of an eye medication for macular degeneration. This innovation could significantly reduce the frequency of injections needed, potentially changing the standard of care from monthly to once or twice a year.
Researchers have identified glycolysis as a key mechanism for endothelial cell energy production and blood vessel formation. Blocking glycolysis could prevent excessive angiogenesis in diseases like cancer, offering new therapeutic options.
Researchers aim to prevent diabetes-related damage to blood vessels in the retina by modulating the arginase enzyme. By stabilizing arginase levels, they hope to restore a healthy relationship between enzymes and reduce oxidative stress. This new approach may not only protect sight but also have broader benefits for cardiovascular health.
Combining certain foods like tomatoes, broccoli, and olive oil may enhance their antiangiogenesis abilities, research suggests. Developing these food products will require extensive tests in food safety and efficacy.
Researchers at UCL Institute of Ophthalmology identify LRG1 as a protein responsible for abnormal blood vessel growth in diseases like cancer, macular degeneration, and rheumatoid arthritis. Inhibition of LRG1 may be a promising target for future therapy.
Researchers at Johns Hopkins Medicine have successfully grown new blood vessels from pluripotent stem cells and transplanted them into mice, a crucial step towards developing personalized treatments. The new technique could enable genetically matched blood vessels that are less likely to be rejected by patients' immune systems.
Scientists have developed a method to generate functional blood vessels lasting up to nine months using human induced pluripotent stem cells. The breakthrough could lead to new treatments for cardiovascular disease and diabetes.
A recent study by University of South Florida researchers found that a cardiac hormone signaling receptor plays a key role in the link between inflammation and cancer-causing tumors. By blocking this receptor, scientists hope to develop new treatments that cut off tumor growth by cutting off blood supply. The research aims to create in...
A new study confirms that the body generates hydrogen sulfide (H2S) as a signaling molecule for cardiovascular health. The researchers developed a chemical probe that reacts with H2S and allows them to visualize its presence in live human cells.
Researchers discovered how malaria parasites stick to blood vessels by binding to endothelial protein C receptor (EPCR). This finding may lead to new means of combating malaria, including vaccines and drugs. The discovery sheds light on the mechanisms behind severe malaria symptoms.
A new study found that wider retinal venules are associated with lower IQ scores and cognitive deficits in older adults, even after accounting for health and lifestyle factors. The findings suggest that the processes linking vascular health and cognitive functioning begin much earlier than previously assumed.
A study published in Nature Medicine reveals that a mutation in the Semaphorin 3d molecule disrupts the development of pulmonary veins, leading to Total Anomalous Pulmonary Venous Connection (TAPVC). The condition causes poorly oxygenated blood throughout the body, resulting in cyanosis. Researchers found that Sema3d mutations cause ab...
Researchers have discovered that carnitine supplements can normalize blood vessel dysfunction associated with congenital heart defects and even prevent damage after corrective surgery. High daily doses of carnitine for the first four weeks of life may also prevent endothelial dysfunction in children with heart defects.
A study found that a diet low in grains, beans, and certain vegetables combined with anti-aging supplements improved blood vessel function. Patients consumed a restricted diet and took antioxidants to slow cell aging, potentially reversing high blood pressure, diabetes, and obesity.
Researchers at UNC have identified a key regulatory switch that controls the development of blood vessels. Disrupting this gene, CASZ1, can prevent proper vessel formation and lead to cardiovascular disease. Further study may reveal new therapeutic targets for treating cardiovascular disease.
A study published in Cell Metabolism suggests that macrophage cholesterol accumulation contributes to macular degeneration. Researchers found that eye drops could reduce blood vessel growth and prevent blindness by targeting cholesterol regulators.
A study found that each seven-gram increase in total daily fiber intake was associated with a 7 percent decrease in first-time stroke risk. Increasing fiber intake can help reduce risk factors for stroke, including high blood pressure and high LDL cholesterol levels.
A study of hospital patients found that transfusing donated blood more than three weeks old impairs blood vessel function, a mechanism linked to nitric oxide deficiency. The results suggest that older blood may be detrimental to patient health, particularly in cardiovascular surgery or critical care scenarios.
Scientists identified nitric oxide's role in degrading a protein that attenuates cardiac growth, linking vascular changes to heart size. A nanogel-based treatment targeting an immunosuppressive drug directly to tissues associated with immune cells may help treat systemic lupus erythematosus.
Researchers at Yale University identified a molecular mechanism by which the growth of new blood vessels and heart muscle are coordinated. Nitric oxide triggers the destruction of RGS4, allowing for physiological changes associated with the relaxation of blood vessels, while promoting cardiac growth.
Researchers at the University of Georgia have identified a new target for stroke treatments using candesartan, which increases brain-derived neurotrophic factor and stimulates angiogenesis. This approach has the potential to improve recovery outcomes for stroke patients and may also benefit veterans with traumatic brain injuries.
Researchers have decoded the entire pathway regulating blood vessel leakiness, a condition linked to disorders like heart disease and cancer. Several agents already being tested for other conditions may reverse vessel leakiness, offering new directions for clinical treatment.
A study has identified two enzymes elevated in prediabetes that could lead to new therapies for vascular complications and help predict who is at risk of developing diabetes. Elevated arginase and indoleamine 2,3 dioxygenase trigger a stress response that damages blood vessels and immune cells.
A new study published in Circulation reveals that the arginase enzyme may play a key role in the development of cardiovascular disease in patients with type II diabetes. Inhibiting this enzyme improves blood vessel function in diabetics with angina, but has no effect on healthy individuals or those without angina.
A study reveals that kidney failure patients have less of the sugar coating on their blood vessels, leading to high levels of its constituents in the blood. This damage may contribute to their increased risk of heart problems.
Researchers at the University of Helsinki have discovered stem cells that play a crucial role in new blood vessel growth, offering new opportunities in treating cardiovascular diseases, cancer, and other conditions. The discovery could lead to more effective treatments if these cells can be isolated and efficiently produced.
Scientists have identified a new type of stem cell that can generate new blood vessels, offering new possibilities for treating cardiovascular disease and cancer. The discovery could lead to the development of new therapeutics to prevent or stimulate neoangiogenesis.
Researchers at the University of Iowa Health Care have discovered a new biological pathway that can be targeted to eliminate or reduce severe side effects of diabetes drugs. The study identified the Cullin-3 pathway as key to blood pressure-lowering effects, potentially leading to more specific and effective treatments.
A new Hopkins study found that monthly injections of ranibizumab improve eye chart test results, build driver confidence, and keep those with wet AMD driving longer. This treatment may help elderly individuals maintain their independence by continuing to drive despite vision loss.
Researchers studied mouse offspring to investigate the effects of high-fat diet during pregnancy on microcirculation networks. The study, funded by the British Heart Foundation, aims to understand how maternal diet influences adult diseases like obesity and diabetes.
A study by the American Heart Association found that transient ischemic attacks (TIAs) and minor strokes can cause significant disability in up to 15% of patients. Thrombolysis treatment may be necessary for these patients, even if symptoms appear mild, to prevent further damage.